Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax - Wikidata - wikimedia - TriplyDB

Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax

Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax

http://www.wikidata.org/entity/Q36870766

about

Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections Novel and unique diagnostic biomarkers for Bacillus anthracis infection.Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model Comparison of the efficacy and safety of oritavancin front-loaded dosing regimens to daily dosing: an analysis of the SIMPLIFI trial.Reversing resistance: The next generation antibacterials.Recombinant Sindbis virus vectors designed to express protective antigen of Bacillus anthracis protect animals from anthrax and display synergy with ciprofloxacin.Dalbavancin and Oritavancin: An Innovative Approach to the Treatment of Gram-Positive Infections.Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review.Oritavancin: a long-acting antibacterial lipoglycopeptide.Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model.In vivo activity of oritavancin in animal infection models and rationale for a new dosing regimen in humans.

P2860

Q26799701-C8F87012-8EFD-4D31-A1A6-FE1A115C031E Q30157179-3F231775-A50D-4277-84A5-6D15A92A5436 Q33676316-A89E93B1-04F9-4696-857E-181ACD98FA94 Q35065786-8C31BD9B-5CA0-4C63-A4DF-255944AF4258 Q35669688-6E841EDD-7CC6-4F4C-B29B-98787E7BAB90 Q37410033-2DD5B0A8-B0DB-48AA-857C-675E29FEC9B5 Q38615330-126B1E70-6E1A-4720-AD28-61498386B754 Q38646905-B0B7D600-0B18-408B-9669-5CAB26EE8A7E Q38830176-D5CAA622-15B3-4B91-A436-7CF545ED9374 Q47976373-FF91DFCC-3824-4B8B-A8CF-B8BE11069E50 Q51760113-68B02266-0CDF-41D3-958A-2372DCF3B361

P2860

Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax

http://www.wikidata.org/entity/Q36870766

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax

@en

type

label

Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax

@en

prefLabel

Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax

@en

P1433

Q36870766-1970AF2B-FEAD-4C60-9197-79E76DC93881

P1476

Q36870766-C8114365-673A-4D50-A603-FC5050FA0745

P2093

Q36870766-1B082EFA-908B-4E45-A5AB-526C0A1E087F

Q36870766-1D0A3B2B-E055-4A03-9E01-42C04797FA9D

Q36870766-32E76653-0AD8-4878-9B0A-571080418217

Q36870766-7B7338EB-CBA3-48ED-8B9F-6E83C88A34C2

Q36870766-ADD8FAD9-4EF3-4D98-9592-A4FD57EEB114

Q36870766-B023F61B-F5A5-4D60-99E3-52D0777E9CB9

Q36870766-B83D58DB-AC0F-4D54-B8A3-2895CD4723DE

Q36870766-DB3B00AB-6540-41DD-9739-964D04B86E57

P2860

Q36870766-07961260-7105-4736-9149-840EEB7E8160

Q36870766-1B08710B-49A1-4802-B86E-5CAD4252ECC4

Q36870766-1E885BE8-2D08-4778-8BB1-77AA6C6759BA

Q36870766-22686273-E51B-45D3-9E17-9A2BC7B4B4EE

Q36870766-242076DC-E0B4-4C20-AC40-82D8FBF8D7E7

Q36870766-26039206-E489-4F22-A4C1-042EBCC647CC

Q36870766-4038E330-A7A5-4054-BA50-E62B6D018AC8

Q36870766-48921A6B-92B7-4796-92C8-73EAA0FC3698

Q36870766-48D60A4E-997E-4C4D-87D3-2A5CB6675AF0

Q36870766-50E5A9ED-9EDA-4926-A0D5-11F17F5424A9

P304

Q36870766-F13DCA6A-3A5A-4E49-B7EF-9823470E619E

P31

Q36870766-BC043145-46C4-4C29-B17C-1DDA76573C21

P356

Q36870766-1A039373-4461-4FDE-9F0A-48BE96113C90

P407

Q36870766-1A75B202-C534-4F71-9571-79804851ED11

P433

Q36870766-C17938CD-F490-4675-A6D1-D1C5BD47AB8A

P478

Q36870766-8BE10CFD-645B-41A8-AA32-5E2973902180

P50

Q36870766-FCFF937E-6F47-427D-82B7-19D27244EB91

P577

Q36870766-913E8666-E5EC-4003-ABEA-5A6CE3D9083A

P698

Q36870766-7C2C0933-3BFA-40C6-813C-3B286CB03F19

P932

Q36870766-ABCFF474-24CE-4AE3-9007-4304D71237DF

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax

@en

P2093

A Bassett

http://www.w3.org/2001/XMLSchema#string

B E Ivins

http://www.w3.org/2001/XMLSchema#string

D Lehoux

http://www.w3.org/2001/XMLSchema#string

F F Arhin

http://www.w3.org/2001/XMLSchema#string

H S Heine

http://www.w3.org/2001/XMLSchema#string

J Bassett

http://www.w3.org/2001/XMLSchema#string

L Miller

http://www.w3.org/2001/XMLSchema#string

T R Parr

http://www.w3.org/2001/XMLSchema#string

P2860

Anthrax as a biological weapon, 2002: updated recommendations for management

Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose.

Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis.

Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.

Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.

Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.

Pharmacodynamics of oritavancin (LY333328) in a neutropenic-mouse thigh model of Staphylococcus aureus infection

Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis.

Mechanism of action of oritavancin and related glycopeptide antibiotics.

US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax.

P304

3350-3357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00360-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18606841

http://www.w3.org/2001/XMLSchema#string

P932

2533456

http://www.w3.org/2001/XMLSchema#string